{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:42:51Z","timestamp":1772001771488,"version":"3.50.1"},"reference-count":28,"publisher":"Termedia Sp. z.o.o.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Med Sci"],"published-print":{"date-parts":[[2021,5,6]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The incidence of hepatitis E virus (HEV) infections in Poland is largely unknown. This study aimed to describe seroprevalence of markers of HEV infection among patients with immunodeficiency of diverse etiology and patients with advanced chronic liver diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>Four hundred fifty patients were enrolled; among them, 180 persons were solid organ transplant recipients, 90 patients were HIV-infected and 180 persons had confirmed liver cirrhosis of different etiology. Serum anti-HEV-IgG, IgM antibodies and HEV-antigen were detected by ELISA (Wantai, China).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the group of transplant recipients, serum anti-HEV-IgG antibodies were detected in 40.6%, IgM in 1.1% and HEV-Ag in 2.8% of subjects. In the HIV-infected population 37.7% had anti-HEV-IgG, 1.1% had anti-HEV-IgM and none had HEV-Ag. Among patients with advanced chronic liver diseases the highest prevalence of anti-HEV-IgG was recorded in alcohol-related liver cirrhosis (52.1%) (p = 0.049). In the population of all liver cirrhotics anti-HEV-IgG seroprevalence was 48.3%, anti-HEV-IgM seroprevalence was 5.0% and HEV-Ag seroprevalence was 1.7%. Older age and male gender were significant risk factors associated with increased anti-HEV-IgG prevalence, p = 0.0004 and p = 0.02, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this large cohort a\u00a0high seroprevalence of anti-HEV-IgG was detected in comparison to other European countries, with the highest rates in patients with alcoholic liver disease and in transplant recipients.<\/jats:p><\/jats:sec>","DOI":"10.5114\/aoms.2018.79958","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T10:41:37Z","timestamp":1545043297000},"page":"675-681","source":"Crossref","is-referenced-by-count":7,"title":["High prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disorders in eastern Poland"],"prefix":"10.5114","volume":"17","author":[{"given":"Anna","family":"Parfieniuk-Kowerda","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Bialystok, \nBialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Jaroszewicz","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Bialystok, \nBialystok, Poland"},{"name":"Department of Infectious Diseases and Hepatology in Bytom, Medical University \nof Silesia, Bytom, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadeusz W.","family":"\u0141api\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Bialystok, \nBialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"\u0141ucejko","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Bialystok, \nBialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Maciaszek","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Bialystok, \nBialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"\u015awiderska","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Bialystok, \nBialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Grzeszczuk","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Bialystok, \nBialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Naumnik","sequence":"additional","affiliation":[{"name":"Department of Nephrology with Dialysis Unit, Medical University of Bialystok, \nBialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miros\u0142aw","family":"Rowi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Nephrology with Dialysis Unit, Medical University of Bialystok, \nBialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Flisiak","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology, Medical University of Bialystok, \nBialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"ref-518328","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.109.192665","article-title":"Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association","volume":"121","author":"Baddour LM","year":"2010","unstructured":"Baddour LM, Epstein AE, Erickson CC, et al. (2010). Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association Circulation. 121: 458-77.","journal-title":"Circulation"},{"key":"ref-518329","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ahj.2003.06.005","article-title":"Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999","volume":"147","author":"Cabell CH","year":"2004","unstructured":"Cabell CH, Heidenreich PA, Chu VH, et al. (2004). Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999 Am Heart J. 147: 582-6.","journal-title":"Am Heart J"},{"key":"ref-518330","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/europace\/eus284","article-title":"Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients","volume":"15","author":"Herc\u00e9 B","year":"2013","unstructured":"Herc\u00e9 B, Nazeyrollas P, Lesaffre F, et al. (2013). Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients Europace. 15: 66-70.","journal-title":"Europace"},{"key":"ref-518331","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.hrthm.2010.05.016","article-title":"Cardiac implantable electronic device infections: presentation, management, and patient outcomes","volume":"7","author":"Tarakji KG","year":"2010","unstructured":"Tarakji KG, Chan EJ, Cantillon DJ, et al. (2010). Cardiac implantable electronic device infections: presentation, management, and patient outcomes Hear Rhythm. 7: 1043-7.","journal-title":"Hear Rhythm"},{"key":"ref-518332","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijcard.2016.11.029","article-title":"Device-related infective endocarditis in cardiac resynchronization therapy recipients \u2013 single center registry with over 2500 person-years follow up","volume":"227","author":"J\u0119drzejczyk-Patej E","year":"2017","unstructured":"J\u0119drzejczyk-Patej E, Mazurek M, Kowalski O, et al. (2017). Device-related infective endocarditis in cardiac resynchronization therapy recipients \u2013 single center registry with over 2500 person-years follow up Int J Cardiol. 227: 18-24.","journal-title":"Int J Cardiol"},{"key":"ref-518333","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/heartjnl-2012-301627","article-title":"Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study","volume":"98","author":"Deharo JC","year":"2012","unstructured":"Deharo JC, Quatre A, Mancini J, et al. (2012). Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study Heart. 98: 724-31.","journal-title":"Heart"},{"key":"ref-518334","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang ASL","year":"2010","unstructured":"Tang ASL, Wells GA, Talajic M, et al. (2010). Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med. 363: 2385-95.","journal-title":"N Engl J Med"},{"key":"ref-518335","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/eurjhf\/hfs055","article-title":"Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial","volume":"14","author":"Cleland JGF","year":"2012","unstructured":"Cleland JGF, Freemantle N, Erdmann E, et al. (2012). Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial Eur J Heart Fail. 14: 628-34.","journal-title":"Eur J Heart Fail"},{"key":"ref-518336","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.5114\/aoms.2017.65660","article-title":"Modalities of ventricular pacing for cardiac resynchronization therapy in patients with heart failure: a meta-analysis and systematic review","volume":"13","author":"Chen A","year":"2017","unstructured":"Chen A, Chen X, Shen Y, Li W. (2017). Modalities of ventricular pacing for cardiac resynchronization therapy in patients with heart failure: a meta-analysis and systematic review Arch Med Sci. 13: 1006-17.","journal-title":"Arch Med Sci"},{"key":"ref-518337","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the management of infective endocarditis","volume":"36","author":"Habib G","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, et al. (2015). 2015 ESC Guidelines for the management of infective endocarditis Eur Heart J. 36: 3075-128.","journal-title":"Eur Heart J"},{"key":"ref-518338","first-page":"275","article-title":"Cardiac device infections: definition, classification, differential diagnosis, and management","volume":"126","author":"Polewczyk A","year":"2016","unstructured":"Polewczyk A, Janion M, Kutarski A. (2016). Cardiac device infections: definition, classification, differential diagnosis, and management Pol Arch Med Wewn. 126: 275-83.","journal-title":"Pol Arch Med Wewn"},{"key":"ref-518339","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s10096-014-2117-8","article-title":"Clinical manifestations of lead-dependent infective endocarditis: analysis of 414 cases","volume":"33","author":"Polewczyk A","year":"2014","unstructured":"Polewczyk A, Janion M, Podlaski R, Kutarski A. (2014). Clinical manifestations of lead-dependent infective endocarditis: analysis of 414 cases Eur J Clin Microbiol Infect Dis. 33: 1601-8.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref-518340","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1161\/01.CIR.95.8.2098","article-title":"Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management","volume":"95","author":"Klug D","year":"1997","unstructured":"Klug D, Lacroix D, Savoye C, et al. (1997). Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management Circulation. 95: 2098-107.","journal-title":"Circulation"},{"key":"ref-518341","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4065\/83.1.46","article-title":"Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection","volume":"83","author":"Sohail MR","year":"2008","unstructured":"Sohail MR, Uslan DZ, Khan AH, et al. (2008). Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection Mayo Clin Proc. 83: 46-53.","journal-title":"Mayo Clin Proc"},{"key":"ref-518342","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.hrthm.2016.10.007","article-title":"Lead-related infective endocarditis: factors influencing early and long-term survival in patients undergoing transvenous lead extraction","volume":"14","author":"Polewczyk A","year":"2017","unstructured":"Polewczyk A, Jache\u0107 W, Tomaszewski A, et al. (2017). Lead-related infective endocarditis: factors influencing early and long-term survival in patients undergoing transvenous lead extraction Hear Rhythm. 14: 43-9.","journal-title":"Hear Rhythm"},{"key":"ref-518343","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.5114\/aoms.2016.58635","article-title":"Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy","volume":"13","author":"Ptaszynska-Kopczynska K","year":"2017","unstructured":"Ptaszynska-Kopczynska K, Szpakowicz A, Marcinkiewicz-Siemion M, et al. (2017). Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy Arch Med Sci. 13: 1069-77.","journal-title":"Arch Med Sci"},{"key":"ref-518344","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1388-9842(01)00137-4","article-title":"Activation of the cardiac interleukin-6 system in advanced heart failure","volume":"3","author":"Plenz G","year":"2001","unstructured":"Plenz G, Song ZF, Tjan TD, et al. (2001). Activation of the cardiac interleukin-6 system in advanced heart failure Eur J Heart Fail. 3: 415-21.","journal-title":"Eur J Heart Fail"},{"key":"ref-518345","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/europace\/eus044","article-title":"Microbiology of cardiac implantable electronic device infections","volume":"14","author":"Bongiorni MG","year":"2012","unstructured":"Bongiorni MG, Tascini C, Tagliaferri E, et al. (2012). Microbiology of cardiac implantable electronic device infections Europace. 14: 1334-9.","journal-title":"Europace"},{"key":"ref-518346","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jac\/dku383","article-title":"Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE)","volume":"70","author":"Sandoe JAT","year":"2015","unstructured":"Sandoe JAT, Barlow G, Chambers JB, et al. (2015). Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE) J Antimicrob Chemother. 70: 325-59.","journal-title":"J Antimicrob Chemother"},{"key":"ref-518347","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10840-010-9537-x","article-title":"Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections","volume":"31","author":"Sohail MR","year":"2011","unstructured":"Sohail MR, Hussain S, Le KY, et al. (2011). Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections J Interv Card Electrophysiol. 31: 171-83.","journal-title":"J Interv Card Electrophysiol"},{"key":"ref-518348","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jacc.2011.11.011","article-title":"Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort)","volume":"59","author":"Greenspon AJ","year":"2012","unstructured":"Greenspon AJ, Prutkin JM, Sohail MR, et al. (2012). Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) J Am Coll Cardiol. 59: 681-7.","journal-title":"J Am Coll Cardiol"},{"key":"ref-518349","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1540-8159.2008.01039.x","article-title":"Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus","volume":"31","author":"Greenspon AJ","year":"2008","unstructured":"Greenspon AJ, Rhim ES, Mark G, Desimone J, Ho RT. (2008). Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus Pacing Clin Electrophysiol. 31: 548-53.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref-518350","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5114\/aoms.2016.59260","article-title":"Impact of septal flash and left ventricle contractile reserve on positive remodeling during 1 year cardiac resynchronization therapy: the multicenter ViaCRT study","volume":"12","author":"G\u0105sior Z","year":"2016","unstructured":"G\u0105sior Z, P\u0142o\u0144ska-Go\u015bciniak E, Ku\u0142ach A, et al. (2016). Impact of septal flash and left ventricle contractile reserve on positive remodeling during 1 year cardiac resynchronization therapy: the multicenter ViaCRT study Arch Med Sci. 12: 349-52.","journal-title":"Arch Med Sci"},{"key":"ref-518351","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0735-1097(02)01932-0","article-title":"Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study","volume":"40","author":"Linde C","year":"2002","unstructured":"Linde C, Leclercq C, Rex S, et al. (2002). Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study J Am Coll Cardiol. 40: 111-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref-518352","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1161\/01.CIR.89.6.2684","article-title":"Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers","volume":"89","author":"Vilacosta I","year":"1994","unstructured":"Vilacosta I, Sarri\u00e1 C, San Rom\u00e1n JA, et al. (1994). Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers Circulation. 89: 2684-7.","journal-title":"Circulation"},{"key":"ref-518353","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/hrt.81.1.82","article-title":"Pacemaker lead infection: echocardiographic features, management, and outcome","volume":"81","author":"Victor F","year":"1999","unstructured":"Victor F, De Place C, Camus C, et al. (1999). Pacemaker lead infection: echocardiographic features, management, and outcome Heart. 81: 82-7.","journal-title":"Heart"},{"key":"ref-518354","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/europace\/eus240","article-title":"Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects","volume":"15","author":"Golzio PG","year":"2013","unstructured":"Golzio PG, Fanelli AL, Vinci M, et al. (2013). Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects Europace. 15: 89-100.","journal-title":"Europace"},{"key":"ref-518355","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jcmg.2014.01.015","article-title":"Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry","volume":"7","author":"Greenspon AJ","year":"2014","unstructured":"Greenspon AJ, Le KY, Prutkin JM, et al. (2014). Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry JACC Cardiovasc Imaging. 7: 541-9.","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Archives of Medical Science"],"original-title":[],"link":[{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-91733-64234","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-91733-64234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T09:32:23Z","timestamp":1626427943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.archivesofmedicalscience.com\/High-prevalence-of-anti-HEV-antibodies-among-patients-with-immunosuppression-and,91733,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["91733"],"URL":"https:\/\/doi.org\/10.5114\/aoms.2018.79958","relation":{},"ISSN":["1734-1922","1896-9151"],"issn-type":[{"value":"1734-1922","type":"print"},{"value":"1896-9151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}